The results for HER2-enriched (ER-negative/PR-negative/HER2-positive) and triple-negative (ER-negative/PR-negative/HER2-negative) breast cancers differed from those for luminal (ER-positive/PR-positive) breast cancer. The gene discussed is ERBB2; the disease is breast cancer.